Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies

Lantheus Holdings, Inc. (the „Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. („LMI”), a global …

Lantheus Holdings, Inc. (the "Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. ("LMI”), a global ...